PE20010517A1 - THE EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES - Google Patents

THE EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES

Info

Publication number
PE20010517A1
PE20010517A1 PE2000000854A PE0008542000A PE20010517A1 PE 20010517 A1 PE20010517 A1 PE 20010517A1 PE 2000000854 A PE2000000854 A PE 2000000854A PE 0008542000 A PE0008542000 A PE 0008542000A PE 20010517 A1 PE20010517 A1 PE 20010517A1
Authority
PE
Peru
Prior art keywords
compound
alkyl
rinovirus
preparation
produce
Prior art date
Application number
PE2000000854A
Other languages
Spanish (es)
Inventor
Quingping Tian
Naresh K Nayyar
Srinivasan Babu
Junhua Tao
Michael J Melnick
Steven L Bernder
Lennert J Mitchell
Terence J Moran
Raymond Dagnino Jr
Travis P Remarchuk
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Publication of PE20010517A1 publication Critical patent/PE20010517A1/en

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2415—Tubular reactors
    • B01J19/2435—Loop-type reactors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J19/24—Stationary reactors without moving elements inside
    • B01J19/2475—Membrane reactors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00074—Controlling the temperature by indirect heating or cooling employing heat exchange fluids
    • B01J2219/00087—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor
    • B01J2219/00099—Controlling the temperature by indirect heating or cooling employing heat exchange fluids with heat exchange elements outside the reactor the reactor being immersed in the heat exchange medium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
    • B01J2219/00049—Controlling or regulating processes
    • B01J2219/00051—Controlling the temperature
    • B01J2219/00159—Controlling the temperature controlling multiple zones along the direction of flow, e.g. pre-heating and after-cooling

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE REFIERE A UN PROCESO PARA LA SINTESIS DEL COMPUESTO I COMO ETILO-3-{(5`-METILISOXAZOL-3'-CARBONIL)-L-VALÝ(COCH2)-L-(4-F-Phe)-L-((S)-PIRROL-ALA)}-E-PROPANOATO, QUE COMPRENDE a)LA CIANOMETILACION DE UN COMPUESTO V UTILIZANDO BIS(TRIMETISILO)AMIDA Y BROMOACETONITRILO PARA PRODUCIR UN COMPUESTO VI; b)REALIZAR LA DISMINUCION , CICLIZACION, PROTECCION DEL COMPUESTO VI PARA PRODUCIR EL COMPUESTO VII; c)REALIZAR LA OXIDACION Y OLEFINACION DEL COMPEUSTO VII MEDIANTE LA REACCION DEL COMPUESTO VII CON UN COMPLEJO DE SO3-PIRIDINA PARA PRODUCIR UNA MEZCLA DE REACCION Y REACCIONAR CON UN COMPUESTO VIII Y FORMAR UN COMPUESTO IV; R1 ES H, F, ALQUILO, OH, SH, O-ALQUILO; R41 ES H, ALQUILO; X ES GRUPO PROTECTOR DE N; d)DESPROTEGER EL COMPUESTO IV PARA FORMAR UN COMPUESTO IVA; e)SOMETER (R4)(R5)(R6)C-C(=O)-OH Y EL COMPUESTO IVA PARA FORMAR EL COMPUESTO IA, R2 Y R3 SON H, -CH2-CO-NH2, GRUPO a; n ES 0-5; A1 ES CH, N; A2 Y A3 SON C(R41)2, S, ENTRE OTROS; R4 ES R9-CO-NH-C(R7)(R8)-CO-; R5 Y R6 SON H, F, ALQUILO, ENTRE OTROS: R7 Y R8 SON H, ALQUILO, ENTRE OTROS; R9 ES HETEROCICLO DE 5 MIEMBROS; Z Y Z1 SON H, F, ALQUILO, ENTRE OTROS. EL COMPUESTO V ES PREPARADO A PARTIR DE N-BOS L-ACIDO GLUTAMICO þ-BENZILO ESTER. TAMBIEN SE REFIERE A LA PREPARACION DE COMPUESTOS INTERMEDIOS. EL COMPUESTO ES UTIL PARA PREPARAR INHIBIDORES DE PROTEASA DEL RINOVIRUSREFERS TO A PROCESS FOR THE SYNTHESIS OF COMPOUND I AS ETHYL-3 - {(5`-METHYLISOXAZOLE-3'-CARBONYL) -L-VALÝ (COCH2) -L- (4-F-Phe) -L - (( S) -PYRROL-ALA)} - E-PROPANOATE, WHICH INCLUDES a) THE CYANOMETILATION OF A COMPOUND V USING BIS (TRIMETISILO) AMIDE AND BROMOACETONITRILE TO PRODUCE A COMPOUND VI; b) PERFORM THE DECREASE, CYCLING, PROTECTION OF COMPOUND VI TO PRODUCE COMPOUND VII; c) CARRY OUT THE OXIDATION AND OLEFINATION OF THE COMPEUST VII BY REACTIONING THE COMPOUND VII WITH A SO3-PYRIDINE COMPLEX TO PRODUCE A REACTION MIXTURE AND REACT WITH A COMPOUND VIII AND FORM A COMPOUND IV; R1 IS H, F, ALKYL, OH, SH, O-ALKYL; R41 IS H, ALKYL; X IS THE PROTECTIVE GROUP OF N; d) UNPROTECT COMPOUND IV TO FORM A COMPOUND VAT; e) SUBMIT (R4) (R5) (R6) C-C (= O) -OH AND THE COMPOUND IVA TO FORM THE COMPOUND IA, R2 AND R3 ARE H, -CH2-CO-NH2, GROUP a; n IS 0-5; A1 IS CH, N; A2 AND A3 ARE C (R41) 2, S, AMONG OTHERS; R4 IS R9-CO-NH-C (R7) (R8) -CO-; R5 AND R6 ARE H, F, ALKYL, AMONG OTHERS: R7 AND R8 ARE H, ALKYL, AMONG OTHERS; R9 IS A 5-MEMBER HETEROCYCLE; Z AND Z1 ARE H, F, RENT, AMONG OTHERS. COMPOUND V IS PREPARED FROM N-BOS L-GLUTAMIC ACID þ-BENZYL ESTER. IT ALSO REFERS TO THE PREPARATION OF INTERMEDIATE COMPOUNDS. THE COMPOUND IS USEFUL TO PREPARE RINOVIRUS PROTEASE INHIBITORS

PE2000000854A 1999-08-24 2000-08-22 THE EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES PE20010517A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15035899P 1999-08-24 1999-08-24

Publications (1)

Publication Number Publication Date
PE20010517A1 true PE20010517A1 (en) 2001-05-16

Family

ID=22534156

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000854A PE20010517A1 (en) 1999-08-24 2000-08-22 THE EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES

Country Status (20)

Country Link
EP (1) EP1206450A1 (en)
JP (1) JP2003507453A (en)
KR (1) KR20020046283A (en)
CN (1) CN1168713C (en)
AR (1) AR025380A1 (en)
AU (1) AU770221B2 (en)
BR (1) BR0013306A (en)
CA (1) CA2376452A1 (en)
CO (1) CO5200782A1 (en)
CZ (1) CZ2002632A3 (en)
HK (1) HK1049336B (en)
HU (1) HUP0203365A3 (en)
IL (1) IL147674A0 (en)
MX (1) MXPA02001944A (en)
PE (1) PE20010517A1 (en)
PL (1) PL353997A1 (en)
TW (1) TWI245040B (en)
UY (1) UY26307A1 (en)
WO (1) WO2001014329A1 (en)
ZA (1) ZA200200504B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0400624A2 (en) 1998-04-30 2004-06-28 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds, their preparation and use
CA2380647A1 (en) 1999-08-04 2001-02-15 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
PA8507801A1 (en) 1999-12-03 2002-08-26 Agouron Pharma ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND THE MATERIALS FOR SYNTHESIS
PE20011277A1 (en) 2000-04-14 2002-01-07 Agouron Pharma ANTIPICORNAVIRAL COMPOUNDS AND COMPOSITIONS, THEIR PHARMACEUTICAL USES AND THE MATERIALS FOR THEIR SYNTHESIS
JP2004503533A (en) 2000-06-14 2004-02-05 アグロン・ファーマシュウティカルズ・インコーポレーテッド Anti-picornavirus compounds and compositions, their pharmaceutical use, and substances for their synthesis
CN1309712C (en) * 2004-04-02 2007-04-11 中国科学院上海有机化学研究所 Precursor of key intermediate of AG 7088 class compound and its sythetic process
US20230157998A1 (en) 2020-03-06 2023-05-25 Pfizer Inc. Methods of Inhibiting SARS-CoV-2 Replication and Treating Corona Virus Disease 2019
CN115260074A (en) * 2022-08-02 2022-11-01 爱斯特（成都）生物制药股份有限公司 Preparation method of Paxlovid intermediate of oral antiviral drug
CN115322130B (en) * 2022-08-02 2024-05-14 南京正济医药研究有限公司 Preparation of (S) -2- (BOC-amino) -3- [ (S) -2-oxo-3-pyrrolidinyl ] propanoic acid methyl ester

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GT199700061A (en) * 1996-05-14 1998-11-04 PROCEDURE FOR OBTAINING "ANTIPICORNAVIRAL COMPOUNDS AND METHODS FOR USE AND PREPARATION".
ES2206907T3 (en) * 1997-03-28 2004-05-16 Agouron Pharmaceuticals, Inc. ANTI-PICORNAVIRUS COMPOUNDS, COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEIR USE PROCEDURES.
US5962487A (en) * 1997-12-16 1999-10-05 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds and methods for their use and preparation
HUP0400624A2 (en) * 1998-04-30 2004-06-28 Agouron Pharmaceuticals, Inc. Antipicornaviral compounds, their preparation and use

Also Published As

Publication number Publication date
CO5200782A1 (en) 2002-09-27
CZ2002632A3 (en) 2003-04-16
HUP0203365A3 (en) 2003-12-29
WO2001014329A1 (en) 2001-03-01
EP1206450A1 (en) 2002-05-22
PL353997A1 (en) 2003-12-15
HK1049336B (en) 2005-05-20
AU770221B2 (en) 2004-02-19
UY26307A1 (en) 2001-04-30
KR20020046283A (en) 2002-06-20
MXPA02001944A (en) 2002-10-31
HUP0203365A2 (en) 2003-02-28
CA2376452A1 (en) 2001-03-01
BR0013306A (en) 2002-05-28
AU6797100A (en) 2001-03-19
TWI245040B (en) 2005-12-11
ZA200200504B (en) 2003-03-26
IL147674A0 (en) 2002-08-14
JP2003507453A (en) 2003-02-25
CN1374947A (en) 2002-10-16
CN1168713C (en) 2004-09-29
AR025380A1 (en) 2002-11-20
HK1049336A1 (en) 2003-05-09

Similar Documents

Publication Publication Date Title
BLACK et al. 1, 3-Dipolar cycloaddition reactions of nitrones
JP6399148B2 (en) Substituted pyrrolidines as factor XIa inhibitors for the treatment of thromboembolism
ES2349428T3 (en) USEFUL PHENYLGLYCINAMIDE DERIVATIVES AS ANTICOAGULANTS.
AR054881A1 (en) MACROCICLIC INHIBITORS OF THE REPAIR OF THE VIRUS OF HEPATITIS C, A PROCESS FOR ITS PREPARATION, A PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF HEPATITIS C
ECSP045317A (en) PYRIDINOILPIPERIDINS AS AGONISTS OF 5-HT1F
PE20031012A1 (en) HEPATITIS C INHIBITOR COMPOUND
WO2002048157A2 (en) Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors
JP6337750B2 (en) Compound
PE20010517A1 (en) THE EFFICIENT SYNTHETIC ROUTES FOR THE PREPARATION OF RINOVIRUS PROTEASE INHIBITORS AND KEY INTERMEDIATES
PE49696A1 (en) CARBOCICLIC COMPOUND
CO4950563A1 (en) NEW COMPOUNDS
Hoarau et al. Synthesis of enantiomerically pure (2R, 5S)-and (2R, 5R)-5-hydroxypipecolic acid from glycinate Schiff bases
PE20040750A1 (en) DERIVATIVES OF N- (1-ACETYLPIPERIDIN-4-IL) -4-BENZIDRIL-2-ISOPROPILPIPERAZIN-1-CARBOXAMIDE AS INHIBITORS OF 17BETA-HYDROXIESTEROID DEHYDROGENASE TYPE 3
CN101081851B (en) Preparation method of alpha-aza toroid drug template
HRP960258A2 (en) Method for preparing n,n'-disubstituted cyclic ureas
AR017221A1 (en) OPENING COMPOUNDS OF POTASSIUM CHANNELS, AND THE USE OF THEM FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
CZ381997A3 (en) Process for preparing n-monosubstituted and n, n-disubstituted non-symmetric cyclic ureas
BRPI0616707A2 (en) renin inhibitors, their manufacturing processes and their use
IE49123B1 (en) (1,4)thiazines or thiazepines
ATE555084T1 (en) NEW AMINO ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR THERAPEUTIC USE
ES2432216T3 (en) 2- (1,2-Bencisoxazol-3-yl) benzylamine derivatives
ES2280566T3 (en) ANTIBACTERIAL MACROCICLES.
Confalone et al. A novel synthesis of peptides based on the photochemistry of 5-azido-1, 3, 4-oxadiazoles
JPH10504817A (en) Pyrolinone-based peptide analogs
Robl et al. A synthetic route for the generation of C-7 substituted azepinones

Legal Events

Date Code Title Description
FD Application declared void or lapsed